Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Approves Abbott’s Pain Management Controller App

Executive Summary

The smartphone-compatible app works with Abbott’s implantable neuromodulation technologies as part of its NeuroSphere Digital Care connected care management platform.

You may also be interested in...



Abbott Launches NeuroSphere Virtual Clinic For Remote Neurostim Programming

The US FDA approved Abbott's system that allows physicians to communicate with patients and remotely program their neuromodulation device.

Abbott Sees Signs Of Post-Pandemic Recovery In Q2

Abbott’s medical device sales were down about 20% year-over-year in the second quarter of 2020, but diagnostics sales were up 7%. Procedure trends at the end of the second quarter suggest that demand for devices will soon recover to pre-pandemic levels.

BIO Digital: Investment Panel Sees Continued Rising Adoption Of Telehealth, Remote Monitoring

BIO Digital investment panel sees strong investment opportunities in telehealth, remote monitoring and converging digital products.

Related Content

Topics

Related Companies

Latest News
UsernamePublicRestriction

Register

MT142472

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel